Clinical trial
Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than…
NCT00242320 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00242320 |
|---|---|
| Title | Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119) |
| Official title | The JADE Study: A 12-week, Double-blind, Randomized Study to Investigate the Effect of 500 mcg Roflumilast Tablets Once Daily Versus Placebo on Pulmonary Function in Patients With Chronic Obstructive Pulmonary Disease |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | COPD |
| Intervention type | Drug |
| Interventions | Roflumilast, Placebo |
| Enrollment | 551 |
| Start date | Aug 1, 2005 |
| Primary completion | May 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Oct 20, 2005 |
| Last update posted | Dec 2, 2016 |
| Countries | Hong Kong, Malaysia, Philippines, South Korea, Taiwan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: